腦下垂體 LH 分泌機能檢查。

Gonadotropin; Stimulates the release of luteinizing hormone (LH) from the anterior pituitary gland.

Onset of action: response to therapy usually observed within 2-3 weeks.
Distribution: ~10-15 L.
Metabolism: Primarily renal.
Half-life elimination: Terminal: ~10-40 minutes; increased in patients with renal impairment.
Excretion: Urine (as inactive metabolites).

Hypersensitivity to gonadorelin or any component of the formulation; women with any condition (eg, pituitary prolactinoma) that could be exacerbated by pregnancy; patients who have ovarian cysts; any condition (eg, hormone-dependent tumor) that may be worsened by reproductive hormones.

Superficial thrombophlebitis, injection site irritation, abdominal pain, anaphylactic shock, anaphylaxis, antibody development, erythema at injection site, fever, headache, hypermenorrhea, nausea, ovarian hyperstimulation syndrome.

Intravenously, subcutaneously or intramuscularly：1 amp at a time. If intravenous injection is required, mix 5 to 10 ml of normal saline, glucose injection or water for injection and inject slowly.